The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) — developed by the Defence Research and Development Organisation (DRDO) along with Dr Reddy’s Laboratories (DRL), Hyderabad — was on May 17, 2021 released for emergency use.
from The Hindu - News
Click Here for Full News
No comments:
Post a Comment